← Browse by Condition
Medical Condition

sarcoma

Total Trials
16
Recruiting Now
16
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for sarcoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sarcoma Clinical Trials

How many clinical trials are currently recruiting for sarcoma?
ClinicalMetric currently tracks 16 actively recruiting clinical trials for sarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for sarcoma?
sarcoma research spans Phase 1 (3 trials), Phase 2 (6 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a sarcoma clinical trial?
Eligibility criteria for sarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
3
Phase 2
6
Top Sponsors
Memorial Sloan Kettering Cancer Center 2 trials
AstraZeneca 1 trial
Nationwide Children's Hospital 1 trial
UNC Lineberger Comprehensive Cancer Center 1 trial
Dana-Farber Cancer Institute 1 trial

Recruiting Clinical Trials

NCT07124000
Recruiting
DESTINY-PANTUMOUR04
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT05135975 Phase 2
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Enrollment
86 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06129903
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06073067
Recruiting
GRID Therapy for Extremity Soft Tissue Sarcoma
Enrollment
20 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
View Trial →
NCT04188535
Recruiting
Serial MRI Scans During Radiation Therapy
Enrollment
149 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT06644755 Phase 1
Recruiting
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Enrollment
150 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
View Trial →
NCT01109394
Recruiting
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Enrollment
6,035 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT06074692 Phase 2
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Enrollment
86 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →
NCT07089992 Phase 2
Recruiting
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Enrollment
32 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT07058064
Recruiting
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Enrollment
250 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT03886311 Phase 2
Recruiting
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Enrollment
200 pts
Location
United States
Sponsor
Sarcoma Oncology Research Cent...
View Trial →
NCT06500819 Phase 1
Recruiting
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Enrollment
41 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT04719156 Phase 2
Recruiting
Fluorescent Intra-operative Tumor Margin Examination
Enrollment
110 pts
Location
United States
Sponsor
Kurt Weiss
View Trial →
NCT06710756 Phase 1, Phase 2
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Enrollment
112 pts
Location
United States
Sponsor
Perspective Therapeutics
View Trial →
NCT03978039
Recruiting
National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group
Enrollment
150,000 pts
Location
France
Sponsor
Institut Bergonié
View Trial →
NCT06958107
Recruiting
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health ...
View Trial →

Related Conditions

esophageal cancer (3) neuroblastoma (3) head and neck cancer (2) ovarian cancer (2) prostate cancer (2) vulvar cancer (2) adenocarcinoma nos (1) anal cancer (1) bladder cancer (1) cervical cancer (1) endometrial cancer (1) gall bladder cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology